Improving health equity in Alzheimer's treatment decisions
Using the generalized risk-adjusted cost-effectiveness (GRACE) model to advance health equity in use of novel treatments for Alzheimer's Disease and Related Dementias
['FUNDING_OTHER'] · JOHNS HOPKINS UNIVERSITY · NIH-10975994
This study is looking at how people with Alzheimer's and their families choose new treatments, by talking to them in groups to understand their thoughts on different medication options, so we can help make better decisions together.
Quick facts
| Phase | ['FUNDING_OTHER'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | JOHNS HOPKINS UNIVERSITY (nih funded) |
| Locations | 1 site (BALTIMORE, UNITED STATES) |
| Trial ID | NIH-10975994 on ClinicalTrials.gov |
What this research studies
This research investigates how individuals affected by Alzheimer's Disease and related dementias make decisions about new treatments targeting specific proteins. It involves conducting focus groups to gather insights on the diverse perspectives of patients and their families regarding medication choices. The findings will inform the design of surveys that assess how different treatment attributes are valued, helping to understand the trade-offs patients are willing to make. Ultimately, this approach aims to enhance the decision-making process for patients and caregivers in the context of evolving dementia challenges.
Who could benefit from this research
Good fit: Ideal candidates for this research include individuals diagnosed with Alzheimer's Disease or related dementias, along with their caregivers and family members.
Not a fit: Patients who are not affected by Alzheimer's Disease or related dementias will not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more personalized and equitable treatment options for patients with Alzheimer's Disease and related dementias.
How similar studies have performed: Previous research has shown success in using patient-centered approaches to improve treatment decision-making in various health conditions, indicating potential for this novel approach.
Where this research is happening
BALTIMORE, UNITED STATES
- JOHNS HOPKINS UNIVERSITY — BALTIMORE, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: SEGAL, JODI B. — JOHNS HOPKINS UNIVERSITY
- Study coordinator: SEGAL, JODI B.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions: Alzheimer disease dementia